High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC
- PMID: 29533972
- PMCID: PMC5877691
- DOI: 10.3390/ijms19030830
High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC
Abstract
The clinical impact of the expression of NOTCH1 signaling components in squamous cell carcinoma of the pharynx and larynx has only been evaluated in subgroups. The aim of this study was therefore to evaluate NOTCH1 expression in head and neck squamous cell cancer (HNSCC) patient tissue and cell lines. We analyzed tissue from 195 HNSCCs and tissue from 30 normal patients for mRNA expression of NOTCH1, NOTCH3, HES1, HEY1, and JAG1 using quantitative real-time PCR. Association of expression results and clinical orpathological factors was examined with multivariate Cox regression. NOTCH1 expression was determined in three Human Papilloma Virus (HPV)-positive and nine HPV-negative HNSCC cell lines. High expression of NOTCH1 was associated with better overall survival (p = 0.013) and disease-free survival (p = 0.040). Multivariate Cox regression confirmed the significant influence of NOTCH1 expression on overall survival (p = 0.033) and disease-free survival (p = 0.029). A significant correlation was found between p16 staining and NOTCH1 mRNA expression (correlation coefficient 0.28; p = 0.01). NOTCH1 was expressed at higher levels in HPV-positive HNSCC cell lines compared with HPV-negative cell lines, which was not statistically significant (p = 0.068). We conclude that NOTCH1 expression is associated with overall survival, and that inhibition of NOTCH1 therefore seems less promising.
Keywords: HNSCC; NOTCH signaling; overall survival.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.Cancer Prev Res (Phila). 2015 Apr;8(4):287-95. doi: 10.1158/1940-6207.CAPR-14-0366. Epub 2015 Jan 29. Cancer Prev Res (Phila). 2015. PMID: 25633867 Free PMC article.
-
HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.Oral Oncol. 2018 Jul;82:168-175. doi: 10.1016/j.oraloncology.2018.05.017. Epub 2018 Jun 1. Oral Oncol. 2018. PMID: 29909892
-
Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.Auris Nasus Larynx. 2017 Aug;44(4):447-457. doi: 10.1016/j.anl.2016.08.003. Epub 2016 Aug 29. Auris Nasus Larynx. 2017. PMID: 27595504
-
The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.J Dent Res. 2018 Jun;97(6):645-653. doi: 10.1177/0022034518760297. Epub 2018 Feb 28. J Dent Res. 2018. PMID: 29489439 Free PMC article. Review.
-
NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.Cells. 2020 Dec 12;9(12):2677. doi: 10.3390/cells9122677. Cells. 2020. PMID: 33322834 Free PMC article. Review.
Cited by
-
PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes NOTCH1 and FAT1 to Repress HNSCC Cell Proliferation.Biomedicines. 2022 Nov 16;10(11):2948. doi: 10.3390/biomedicines10112948. Biomedicines. 2022. PMID: 36428516 Free PMC article.
-
Chemically-Induced DNA Damage, Mutagenesis, and Cancer.Int J Mol Sci. 2018 Jun 14;19(6):1767. doi: 10.3390/ijms19061767. Int J Mol Sci. 2018. PMID: 29899224 Free PMC article. No abstract available.
-
Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.PLoS One. 2020 Jan 15;15(1):e0227408. doi: 10.1371/journal.pone.0227408. eCollection 2020. PLoS One. 2020. PMID: 31940393 Free PMC article.
-
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.Signal Transduct Target Ther. 2024 May 27;9(1):128. doi: 10.1038/s41392-024-01828-x. Signal Transduct Target Ther. 2024. PMID: 38797752 Free PMC article. Review.
-
Next-Cell Hypothesis: Mechanism of Obesity-Associated Carcinogenesis.Adv Exp Med Biol. 2024;1460:727-766. doi: 10.1007/978-3-031-63657-8_25. Adv Exp Med Biol. 2024. PMID: 39287871 Review.
References
-
- Hoellein A., Pickhard A., von Keitz F., Schoeffmann S., Piontek G., Rudelius M., Baumgart A., Wagenpfeil S., Peschel C., Dechow T., et al. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Oncotarget. 2011;2:599–609. doi: 10.18632/oncotarget.311. - DOI - PMC - PubMed
-
- Reiter R., Gais P., Jutting U., Steuer-Vogt M.K., Pickhard A., Bink K., Rauser S., Lassmann S., Hofler H., Werner M., et al. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin. Cancer Res. 2006;12:5136–5141. doi: 10.1158/1078-0432.CCR-05-1650. - DOI - PubMed
-
- Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., Forastiere A., Gillison M.L. Improved Survival of Patients with Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial. J. Natl. Cancer Inst. 2008;100:261–269. doi: 10.1093/jnci/djn011. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous